You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid vaccination for people between 18-44 yrs in Delhi to start on Monday

Delhi Chief Minister Arvind Kejriwal made the announcement

Coronavirus | Coronavirus Tests | Coronavirus Vaccine

ANI  |  General News 


Large-scale vaccination against COVID-19 for people between 18 years and 44 years in the national capital will start on Monday, said Delhi Chief Minister Arvind Kejriwal.

Speaking to ANI, the chief minister said, "Vaccination for people between 18-44 years started at only one centre. This is symbolic only. We have received 4.5 lakh vaccine doses. It is being distributed in all districts. Large-scale vaccination in Delhi will begin from the day after tomorrow. There is no walk-in for now. I request people to come only with registration and appointment."

Asked about the shortage of oxygen in Delhi hospitals, Kejriwal said, "There is a major issue of oxygen. SOS is coming from all hospitals. We have spoken in the court and written to the Centre that Delhi requires 976 tons of oxygen daily but we have been allotted only 490 tons of oxygen. Yesterday we received only 312 tons. How will this work?"

"I request the decision-makers with folded hands to provide oxygen to Delhi. People are waiting outside of hospitals just because of the shortage of oxygen. We have prepared 5000 beds at Radha Soami Centre but only 150 functional as there is no oxygen. We prepared 1300 beds at Commonwealth Games and Yamuna Sports Complex. We have prepared 2500 beds in Burari. If we get oxygen, there will be 9000 oxygenated beds in Delhi within 24 hours," stated the chief minister.

Hospitals in the national capital are grappling with the acute shortage of oxygen due to a surge in COVID-19 cases.

The Centre on April 19 had announced a ''liberalised'' policy, making all above 18 years of age eligible to get vaccinated from May 1. It has also allowed state governments and private hospitals to purchase vaccines from manufacturers. Per the revised rules, the centre will receive 50 per cent of the vaccines supplied; states and private hospitals will get the remaining doses.

The country had started the COVID-19 vaccination drive on January 16 with two vaccines -- Covishield (Oxford-AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited).

Delhi recorded 375 COVID-19 deaths and over 27,000 new cases with a positivity rate of 32.69 per cent on Friday, according to the state health department. With the addition of fresh infections, the total COVID-19 count of the national capital has gone up to 11,49,333. The city also reported 25,288 recoveries from the disease. This is the ninth consecutive day the city has seen daily fatalities of over 300. A total of 10,33,825 people have been cured of the infection in Delhi while the total death toll stands at 16,147.

The country reported over 4 lakh new COVID-19 cases and 3,523 deaths in the last 24 hours, as per the Union Health Ministry.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, May 01 2021. 17:00 IST